Skip to main content

Table 2 Peri- and post-transplantation data

From: Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome—a single-center study

Variable

Total N = 119

Alive N  = 96

Dead N  = 23

p

Age at transplantation (years)

53.1 (±10.5)

52.7 (±10.0)

55.0 (±12.2)

0.33

Assessment to transplant (years)

2.6 (1.1, 4.3)

1.3 (0.8, 3.5)

2.6 (1.2, 4.3)

0.09

Waiting list time (years)

2.4 (1.1, 4.2)

1.8 (0.7, 3.5)

2.5 (1.1, 4.3)

0.02*

Mycophenolic acid

62 (52.1)

53 (55.2)

9 (39.1)

0.14

Azathioprine

45 (37.9)

31 (32.2)

14 (60.8)

0.07

Prednisolone

119

96 (100)

23 (100)

 

Tacrolimus

57 (47.9)

46 (47.9)

11 (47.8)

0.92

Cyclosporin

45 (37.9)

34 (35.4)

11 (47.8)

0.64

Sirolimus

3 (2.5)

3 (3.1)

0 (0)

 

ACEI/ARB therapy post-transplant

22 (17.6)

20 (20.8)

2 (8.7)

0.18

Mean creatinine at censor (μmol/l)

188 (±38.2)

173 (±116)

253 (±151)

0.02

Biopsy-proven acute rejection

16 (13.4)

15 (15.6)

1 (4.3)

0.15

Delayed graft function

42 (35.3)

29 (30.2)

13 (56.5)

0.02*

  1. Data are numbers with percentage in parentheses, mean ± standard deviation or median (interquartile range). Tests of significance are t-test (parametric), Mann-Whitney (non-parametric) and Chi-square. ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker. *p < 0.05.